Proto Script Pharmaceutical Corp. (OTC Pink: PSCR) operates as a comprehensive medical device and equipment, through its subsidiary, PSP Homecare. Shares of the medical device company are cratering 66.15% on Friday, January 27, 2017. Over the past month, Proto Script Pharmaceutical Corp. has seen average daily volume of 632,209 shares. However, volume of 1.04 million shares or dollar volume of $478,400, has already exchanged hands early during Friday trading.

Shares of Proto Script Pharmaceutical Corp. are cratering Friday, after the company provided an update on its medical device and equipment business, which is ran under the PSP Homecare subsidiary. The subsidiary is currently working on several partnerships with healthcare providers and facilities to help get the company’s medical products. Here is the press release detailing of the planned partnerships:

Proto Script Pharmaceutical Corp. Press Release:

RANCHO CUCAMONGA, CA–(Marketwired – Jan 27, 2017) – Proto Script Pharmaceutical Corp. dba PSP Homecare (“PSP” or the “Company”) ( OTC PINK : PSCR ), a durable medical equipment provider, is pleased to provide this update regarding its development strategy within hospitals, rehabilitation centers, and other medical facilities.

PSP Homecare is developing new business opportunities via direct partnerships with healthcare institutions providing patient treatment. Through these partnerships, PSP Homecare can establish on-site Medical Supply Storerooms where exclusively PSP Homecare equipment is held for dispensing to patients that discharge from the facility.

“Placing a Medical Supply Storeroom on-site at healthcare facilities, like hospitals and rehabilitation centers, can position essential PSP Homecare products directly at the patient’s point of treatment,” commented Michelle Rico, CEO of Proto Script Pharmaceutical Corp. “By providing convenient access to high quality canes, crutches, walkers, wheelchairs, and other equipment on-site, PSH Homecare can quickly become the preferred supplier for all of their patient discharges, including individuals that are not under contract.”

Michelle Rico concluded, “Following the successful launch of a Medical Supply Storeroom now in operation at a major California inpatient rehabilitation center, we are now planning to rollout in many other hospitals that have expressed an interest setting up similar on-site PSP Homecare operations at their locations.”

Further details regarding PSP Homecare’s planned business expansion and other updates will be made as additional information becomes available.

About Proto Script Pharmaceutical Corp.

Proto Script Pharmaceutical Corp. dba PSP Homecare provides a comprehensive collection of durable medical equipment (DME) like canes, crutches, walkers, commodes, patient lifts, hospital beds, orthotics (braces), wheelchairs, scooters, power wheelchairs, rehabilitation equipment, and accessories. Currently serving California and Nevada, PSP Homecare has specialized in the repair of power wheelchairs and the sale of orthotics since 2011. The Company deals with a growing list of federal, state and private insurance providers such as Medicare, Medi-Cal, Nevada Care and Blue Cross among several others.

Additional information regarding PSP Homecare can be found at www.psphomecare.com.

Proto Script Pharmaceutical Corp. files reports with the Securities & Exchange Commission on EDGAR and anticipates continuing to file such reports. The Company’s filings can be viewed at www.sec.gov.

Cautionary Language Concerning Forward-Looking Statements

This Proto Script Pharmaceutical Corp. press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the Company’s mission statement and growth strategy, are “forward-looking statements.” Although the Company’s management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve a number of risks and uncertainties, which could cause the Company’s future results to differ materially from those anticipated. Potential risks and uncertainties include, among others, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; and the ability to obtain necessary financing on acceptable terms or at all. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update any of the information contained or referenced in this press release.

Add a Comment to this Post

comments